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Abstract: Polymeric micelles with a controlled size in the range between 41 and 80 nm were prepared
by injecting the organic phase through a microengineered nickel membrane or a tapered-end glass
capillary into an aqueous phase. The organic phase was composed of 1 mg¨mL´1 of PEG-b-PCL
diblock copolymers with variable molecular weights, dissolved in tetrahydrofuran (THF) or acetone.
The pore size of the membrane was 20 µm and the aqueous/organic phase volumetric flow rate ratio
ranged from 1.5 to 10. Block copolymers were successfully synthesized with Mn ranging from ~9700 to
16,000 g¨mol´1 and polymeric micelles were successfully produced from both devices. Micelles
produced from the membrane device were smaller than those produced from the microfluidic device,
due to the much smaller pore size compared with the orifice size in a co-flow device. The micelles
were found to be relatively stable in terms of their size with an initial decrease in size attributed to
evaporation of residual solvent rather than their structural disintegration. Fluconazole was loaded
into the cores of micelles by injecting the organic phase composed of 0.5–2.5 mg¨mL´1 fluconazole
and 1.5 mg¨mL´1 copolymer. The size of the drug-loaded micelles was found to be significantly
larger than the size of empty micelles.
Keywords: polymeric micelles; microfluidic co-flow; membrane contactor; fluconazole; drug-loaded
micelles; diblock copolymers
1. Introduction
Micellization is the process of forming oriented colloidal aggregates (micelles) that happens
spontaneously in an aqueous solution of amphiphilic molecules (amphiphiles), composed of
hydrophilic and hydrophobic portions, when its concentration exceeds the critical micelle concentration
(CMC) at a certain temperature [1]. The hydrophilic segments (groups) are located at the surface of
the micelles, whereas the hydrophobic segments form the hydrophobic core. Amphiphilic diblock
copolymers are amphiphiles made up of two distinct homopolymer chains, hydrophobic and
hydrophilic, linked by covalent bonds. The shape of polymeric micelles is believed to be spherical if
the hydrophobic segment is longer than the hydrophilic segment; conversely various non-spherical
structures, including rods and lamellae, may be formed when there is an increase in the length
of the hydrophilic part [2]. Since the polymeric micelles with a diameter of 10–100 nm can be
applied as nanoscale drug carriers, increasing studies on micellar drug delivery systems have been
conducted using block copolymers with poly(ethylene glycol) (PEG) as a hydrophilic segment [3].
Hydrophobic segments of diblock copolymers applied for drug delivery are usually polyester or
poly(amino acid) derivatives. Poly(lactic acid) (PLA), poly(ε-caprolactone) (PCL) and poly(glycolic
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acid) (PGA) are some of the most commonly used hydrophobic segments because of their biocompatible
and biodegradable features [4].
Microfluidics is a research area focusing on transport phenomena in fluids at length scales of less
than 1 mm and typically 1–500 µm [5]. Microfluidic technology has been extensively studied since
the 1990s and applied especially to life and materials sciences and in the pharmaceutical industry.
The benefit of small length scales and precise control of fluid flows was one of the main reasons that
microfluidic technology attracted such great attention [6]. This technology provides the opportunity
to conduct processes such as mixing of fluid streams; mass transfer operations; encapsulation; and
droplet generation and manipulation (merging, splitting, and sorting) continuously with very low
consumptions of materials and to integrate/combine many unit operations on a single chip [7].
Three major configurations of microfluidic mixing and drop generation units are co-flow, T-junction
(cross-flow) and flow-focusing [8,9]. A variety of microfluidic devices have been used to produce
nanoscale particles such as semiconductor quantum dots, metal colloids, liposomes, lipid nanotubes,
polymeric, and composite nanoparticles [6,10–12].
Membrane technology has been widely applied in separation processes [13] and chemical/biochemical
reactors [14]. However, in the past two decades microporous membranes are increasingly used
for production of liquid–liquid, gas–liquid and solid–liquid dispersions, such as emulsions, gas
dispersions and dispersions of micro/nano- particles [15,16]. In membrane dispersion processes,
a membrane does not serve as a separation barrier, but a dispersion medium enabling controlled
injection rates, uniform hydrodynamic conditions at the interface and higher production rates
compared to microfluidic devices.
In this study, micelles composed of various amphiphilic diblock copolymers have been prepared
by flash precipitation initiated by injection of the organic feed stream through a membrane into
the water phase under controlled hydrodynamic conditions. The process is similar to membrane
emulsification, except that the organic phase contains a water-miscible solvent, which diffuses into the
water phase upon mixing causing copolymer molecules dissolved in the organic phase to self-assemble
into micelles. In membrane emulsification, the organic phase contains a water-immiscible solvent or
non-volatile organic liquid (oil).
The process was also investigated using a co-flow microfluidic device composed of two coaxial
glass capillaries inserted into each other. The main objective was to analyze the effects of operating
parameters on the size of micelles produced from both devices and to demonstrate encapsulation of
the drug fluconazole within the micelles.
2. Experimental Section
2.1. Reagents and Materials
Poly(ethylene glycol) methyl ether (Mn ~5000 g¨mol´1) (PEG), ε-caprolactone monomer 99%
(ε-CL), tin(II) 2-ethylhexanoate 95% (Sn(Oct)2), and sodium silicotungstate were supplied by
Sigma-Aldrich, Co Ltd, Gillingham, Dorset, UK. Toluene, extra dry grade, was purchased from
Acros Organics, Geel, Belgium. PEG was dried by azeotropic distillation with toluene prior to the
polymerization reaction. ε-CL was dried prior use by distillation under reduced pressure onto 3A
molecular sieves. Tetrahydrofuran (THF) and acetone of analytical grade were purchased from Fischer
Scientific (Loughborough, UK) and used without further purification. Fluconazole (pharmaceutical
secondary standard, a molecular weight of 306.27 g¨mol´1) was purchased from Sigma-Aldrich and
used for drug loading experiments. Deionized water was obtained from a Millipore Synergy® system
(Ultrapure Water System, Merck Millipore, Darmstadt, Germany).
Polytetrafluoroethylene (PTFE) tubing supplied by Sigma-Aldrich was used for sample collection
(inner diameter (I.D.) = 1.58 mm, outer diameter (O.D.) = 2.16 mm) and organic phase injection
(I.D. = 0.8 mm, O.D. = 1.59 mm) in the microfluidic device. Polyethene (PE) tubing supplied
from Smiths Medical Int’l Ltd, Kent, UK (I.D. = 0.86 mm, O.D. = 1.27 mm) was used for
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aqueous phase injection in the microfluidic device. Borosilicate round capillaries from Intracel
Ltd, St Ives, UK (O.D. = 1.0 mm, I.D. = 0.58 mm) and borosilicate square capillaries from AIT Glass
(O.D. = 1.5 mm, I.D. = 1.05 mm) were used for microfluidic device fabrication. The PTFE tubing
(I.D. = 4.0 mm, O.D. = 6.36 mm) for organic phase injection in membrane experiments was purchased
from Sigma-Aldrich.
2.2. Synthesis of Diblock Copolymers
One gram of PEG and 40% (v/v) ε-CL solution in toluene were dissolved in 20 mL of refluxing
toluene under nitrogen atmosphere. The mole ratio of PEG to ε-CL in the reaction mixture was varied
to produce a PEG:PCL ratio from 1:1.5 to 1:3.0. The polymerization was initiated by the addition
of a 20% (v/v) solution of Sn(Oct)2 in toluene (0.75 w/w) and carried out at 110 ˝C under nitrogen
atmosphere and constant stirring for 18 h. The PEG-b-PCL copolymer was isolated by precipitation in
diethyl ether and dried under vacuum.
2.3. Fabrication of Co-Flow Microfluidic Device
The co-flow microfluidic device (Figure 1) consisted of a 5 cm long tapered-end round capillary
for supplying the organic phase, inserted in a 5 cm coaxial square capillary, which the aqueous
phase flowed through. The round capillary was prepared by pulling apart a whole capillary using
a Flaming-Brown type micropipette puller (P-97, Sutter Instruments, Novato, CA, USA) and then
precisely rubbing the tip with sandpaper to a desired tip diameter. The tip was treated with
2-[methoxy(polyethylenoxy)propyl]trimethoxysilane to enhance the hydrophilicity of its surface.
After flushing the round capillary with water and drying with compressed air, it was inserted into the
square capillary, which had been glued and fixed onto a transparent glass plate. The glue used was
two-component epoxy glue (ITW Devcon Ltd., Shannon, Ireland). Two needles (PrecisionGlide 305175,
Becton Dickinson and Company, Franklin Lakes, NJ, USA), which were cut to remove the sharp tips,
were positioned and glued, one at the end of the round capillary and another at the junction of the
two capillaries. The device was tested by running water through each needle to ensure that no leaking
or blocking was present.
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enhanced flow performance with high accuracy and smooth flow. The microfluidic device was 
placed on the stage of an inverted microscope (GX Microscope XDS-3, GX Optical, Suffolk, UK), 
which was connected to a high speed camera (Phantom v5.1, Vision Research, Wayne, NJ, USA) to 
observe and record live images. A tip size of the microfluidic device was 160 μm. 
2.4.2. Experimental Set-Up for Membrane Device 
The membrane device used in this work was a stirred cell with a flat disc membrane fitted 
under the paddle blade stirrer, as shown in Figure 2a. Similar to the microfluidic device, the organic 
phase was injected into the system through PTFE tubing using a syringe pump. However, unlike the 
microfluidic device, the aqueous phase was fixed in the cell, where a paddle blade stirrer was placed 
in, before injecting organic phase. The membrane used was a nickel membrane with a regular 
Figure 1. ( ) Schem tic diagram f a co-flow glass capillary de ce used in the study and a gnified
schem tic diagram of the co-flow regi n in the device; (b) to v ew of the device; and (c) schematic
diagram of the experimental set-up for co-flow microfluidic experiments.
2.4. Experiment Setup
2.4.1. Experim ntal Setup for Microflui c Device
Figure 1c shows the schematic diagram of the experimental set-up for co-flow microfluidic device
experiments. Organic phase and aqueous phase were separately injected into the microfluidic device
through tubing by syringes (SGE, Victoria, Australia), which were driven by syringe pumps (Harvard
Appar tus; pump 11 Elite, Instech, Plymouth Meeting, PA, USA). This pum offers enhanced flow
performance with high accuracy and smooth flow. The microfluidic device was placed on the stage
of an inverted microscope (GX Microscope XDS-3, GX Optical, Suffolk, UK), which was connected
to a high speed camera (Phantom v5.1, Vision Research, Wayne, NJ, USA) to observe and record live
images. A tip size of the microfluidic device was 160 µm.
2.4.2. Experimental Set-Up fo Membrane Device
The membrane device used in this work was a stirred cell with a flat disc membrane fitted under
the paddle blade stirrer, as shown in Figure 2a. Similar to the microfluidic device, the organic phase was
injected into the system through PTFE tubing using a syringe pump. However, unlike the microfluidic
device, the aqueous phase was fixed in the cell, where a paddle blade stirrer was placed in, before
injecting organic phase. The membrane used was a nickel membrane with a regular hexagonal pore
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array containing cylindrical pores with a diameter of 20 µm, spaced 200 µm from each other. Figure 2c
is a magnified image of the membrane surface taken by an optical microscope. Both stirred cell and
membranes were supplied by Micropore Technologies Ltd. (Hatton, Derbyshire, UK). The agitator
was driven by a 24 V DC motor (PR 3060, GWInstek, New Tapei City, Taiwan) and the paddle rotation
speed was controlled by the applied voltage.
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Figure 2. (a) Schematic diagram of stirred cell with paddle stirrer above a flat disc membrane; Diameter of
stirring blade, D = 32 mm, width of stirring blade, b = 12 mm, diameter of stirred cell, T = 40 mm, and
effective diameter of membrane, Dm = 33 mm. (b) Schematic diagram of the experimental set-up for
membrane device. (c) A micrograph of the membrane surface showing cylindrical pores with constant
pore to pore spacing.
2.5. Experimental Procedure
2.5.1. Experimental Procedure of Microfluidic Experiments
Organic phase solution was prepared by dissolving the certain amount of copolymer (PEG-b-PCL
(A), PEG-b-PCL (B) or PEG-b-PCL (C), weighed by el ctronic weighing b lance) into an appropriate
am unt of org nic solvent (THF or acet ne). The concentration of copolymer in the organic phase was
1 mg¨mL´1. The solution was sonicated in an ultrasonic bath (Fisher Sci ntific, Loughborough, UK)
to ensure that the copolymer was dissolved completely. Syringes with volumes of 5 and 10 mL were
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used for organic and water phase injection, respectively. The water phase was first injected at fixed
flowrate of 5 mL¨h´1 and the organic phase was supplied at 0.1 to 3.33 mL¨h´1, corresponding to
Qa/Qo ratios of 50 to 1.5. Then the organic phase was kept to 0.6 mL¨h´1 with water phase flow rate
changing from 0.1 to 15 mL¨h´1. For the preparation of drug-loaded micelles, the organic phase was
made up of 0.6 mg¨mL´1 of fluconazole and 1.5 mg¨mL´1 of the copolymer in acetone. An ultrasonic
bath was used for dissolving fluconazole and copolymer.
2.5.2. Experimental Procedure of Membrane Experiments
The organic phase for both drug-free and drug-loaded experiments was prepared according to
the procedure explained in Section 2.5.1. The stirred cell (the Dispersion Cell) was filled with 25 mL
of deionized water and the stirring speed was set to 700 rpm. Then, 5 mL of the organic phase was
injected through the membrane for ~31 s at a flow rate of 9.6 mL¨min´1 to achieve a final aqueous to
organic phase volume ratio of 5. The micelle suspension was kept under stirring for 1 min after organic
phase injection. After each experiment, the membrane was sonicated in THF for 1 h. For drug-loaded
micelles, the organic phase was made up of 0.5, 1.0 or 2.5 mg¨mL´1 of fluconazole and 1.0 mg¨mL´1
of the copolymer in acetone. The Zeta potential was measured for drug-loaded and drug-free micelles
for all three copolymers.
2.6. Process Reproducibility Experiments
The experiments conducted under a certain set of conditions were repeated three times in order
to estimate reproducibility of the fabrication process. The conditions for microfluidic experiments
were: Qa = 5 mL¨h´1, Qo = 1.25 mL¨h´1 (Qa/Qo = 4) and the conditions for membrane device were:
Vo = 5 mL, Vw = 25 mL. The organic phase solution for both devices was 1 mg¨mL´1 of the copolymer
PEG-b-PCL (B) dissolved in acetone.
2.7. Micelle Size Measurement
The size of the micelles was measured using Delsa™Nano C particle analyser from Beckman
Coulter Inc., Brea, CA, USA. This equipment uses photon correlation spectroscopy (PCS), which
determines particle size by measuring the rate of fluctuations in laser light intensity scattered by
particles as they diffuse through a fluid. The samples were stored under vacuum to achieve a complete
evaporation of acetone/THF and then transferred to a measuring cuvette (Fisherbrand™ macro, PS,
12.5 mm ˆ 12.5 mm ˆ 40 mm, Fisher Scientific, Loughborough, UK) and placed into the machine.
A refractive index of 1.3300, a viscosity index of 0.89 and dielectric constant of 78.3 were used.
All samples were measured in 3 runs, with each run taking approximately 4 min. The distribution data
and mean size for each run were automatically produced from the software of the particle analyzer.
Average size values for 3 runs were then calculated and recorded.
2.8. Zeta Potential Measurement
The Delsa™Nano C was also used for the measurements of the zeta potential. For this, an alternative
electrophoretic light scattering mode was used with a fixed applied voltage of 60 V.
3. Results and Discussion
3.1. Polymer Characterization
Gel Permeation Chromatography (GPC) was used to determine the molecular weight, polydispersity
index (Mw/Mn), and hydrophilic fractions (f) of the synthetized copolymers. GPC analysis was
performed using an Agilent 1100 High-performance Liquid Chromatography (HPLC) System
(Agilent Technologies, Santa Clara, CA, USA) equipped with a refractive index detector (G1362A).
Analysis was performed on an Agilent PLgel MIXED-C column (Agilent Technologies, Santa Clara,
CA, USA), 5 µm, temperature was 30 ˝C. Calibration was performed using polystyrene standards
with a narrow molecular weight distribution (EasiVials PS-M, Agilent Technologies, Santa Clara, CA,
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USA). The results are listed in Table 1 and include both number-average and weight-average values.
Hydrophilic fraction is the average fraction of the hydrophilic block (PEG) in the copolymer.
Table 1. Number-average molecular weight, Mn, polydispersity index, Mw/Mn (Mw is a weight-average
molecular weight), and hydrophilic fraction (fraction of hydrophilic block to total polymer) by number-
and weight-average molecular weight, respectively, fn and fw, of the synthesized copolymers, as
determined by GPC.
Polymer PEG/PCL Mole Ratio in the Feed Mixture Mn Mw Mw/Mn fn fw
PEG-b-PCL (A) 1:1.5 9666 12,215 1.26 0.62 0.52
PEG-b-PCL (B) 1:2.0 13,070 17,371 1.33 0.46 0.36
PEG-b-PCL (C) 1:3.0 16,027 20,945 1.31 0.37 0.30
Fourier Transformed Infrared Spectroscopy (FTIR) spectra are shown in Figure 3. FTIR spectra
were obtained using a Shimadzu FTIR-8400S spectrometer. A small amount of each material was
mixed with KBr and compressed to tablets. The IR spectra of these tablets were obtained in absorbance
mode and in the spectral region of 600–4000 cm´1 using a resolution of 4 cm´1 and 64 co-added scans.
All materials show characteristic absorptions for PEG, the C-O-C etheric bond bending vibration at
1109 cm´1 and the absorptions at 842 and 1333 cm´1, attributed to PEG crystalline regions. On the
PEG-b-PCL spectra, new absorptions emerge: one at 1724 cm´1 is attributed to stretching of the
esteric carbonyl, while the two at 2935 and 729 cm´1 are due to C-H bond stretching in the PCL block.
Absorptions attributed to the PCL block increase in intensity from PEG-b-PCL (A) to PEG-b-PCL (C) to
PEG-b-PCL (B), as the molecular weight of the hydrophobic block increases, respectively.
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Figure 3. Fourier Transformed Infrared Spectroscopy (FTIR) spectra for Poly(ethylene glycol) (PEG)
and the synthesized Poly(ethylene glycol)-b-poly(ε-caprolactone) copolymers.
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Spectra from Nuclear Magnetic Resonance Spectroscopy (1H-NMR) are shown in Figure 4.
NMR spectra were obtained on a JEOL-ECS-400 NMR spectrometer operating at 400.13 MHz for
protons, employing a 5 mm high-resolution broad-band gradients probe. Spectra were recorded using
the “single-pulse” pulse program with P90 = 10.4 µs covering a sweep width 25.0 ppm (8278 Hz)
with 32,000 time domain data points giving an acquisition time of 3.95 s, Fourier transformed using
64,000 data points and referenced to an internal TMS standard at 0.0 ppm. Absorbencies at 4.0 and
2.3 ppm are due to protons in the PCL block, while the absorbance at 3.3 ppm is due to the three protons
in the methoxy terminal-group of PEG. The absorbance of the PCL block increases in intensity when
the hydrophobic block increases, respectively.
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3.2. Experimental Images from Microfluidic Device
Live images were recorded by the high speed camera and analyzed by the computer software
Image J (v1.46). Figure 5 shows the images recorded under different phase flow rates of the aqueous
(water) and organic phase. From Figure 5a–f, the volumetric flow rate of aqueous phase Qa was fixed
to 5 mL¨h´1 and Qo varied from 0.1 to 3.33 mL¨h´1 to give Qa/Qo values of 50, 16.67, 10, 7, 4 and 1.5,
respectively. From Figure 5g–j, Qo was fixed to 0.6 mL¨h´1 and Qa varied from 0.1 to 15 mL¨h´1 to
give Qa/Qo values of 0.17, 1, 1.67 and 25, respectively. In both Figure 5k,l, Qo was set to 3.33 mL¨h´1
and Qa was 10 or 20 mL¨h´1 to achieve Qa/Qo values of 3 or 6. The shape of organic/aqueous interface
strongly depends on the flow rates of the two phases. At low flow rates, the interface is hemispherical
and resembles the shape observed during generation of droplets in the dripping regime [17,18].
In droplet microfluidics, however, the organic phase eventually detaches from the tip and forms an
isolated droplet in the aqueous phase, whereas in this case, the droplet does not grow on the tip, since
THF and water are miscible in all proportions and the rate of transfer of THF to the interface by the
pump is in equilibrium with the rate of transfer of THF away from the interface due to diffusion
into the aqueous phase. The existence of curved interface is a result of the transient interfacial
tension, the Korteweg stress, which occurs when two miscible fluids are suddenly put into contact [19].
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The transient interfacial tension is given by: σ “ k∆C2{δ, where ∆C is the change in concentration over
the transition zone between two miscible fluids, δ is the thickness of the transition zone, and k is the
proportionality constant. If the organic phase is not injected continuously, the transient tension would
decrease rapidly in proportion to
a
D{t, where D is the diffusion coefficient and t is the interfacial age.
However, because both liquids flow continuously, the Korteweg stress maintains a constant value over
time at any location on the interface.
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Qo = 0.1 mL¨h´1, Qa/Qo = 50; (b) Qa = 5 mL¨h´1, Qo = 0.3 mL¨h´1, Qa/Qo = 16.7; (c) Qa = 5 mL¨h´1,
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Figure 5a applies to all figures from Figure 5a–l. The organic solvent was tetrahydrofuran (THF).
At low organic phase flow rates, Figure 5a–c, the liquid–liquid interface is sharp over the whole
jet boundar , but at higher organic phase flow rates, it becomes blurry (Figure 5e) or even completely
disappears (Figure 5g–i) on the front side of the jet. It can be explained by high THF concentration in the
central region of the capillary, predicted by numerical modeling [11], which leads to low concentration
gradient, ∆C, and negligible Korteweg stress on the front side of the jet. In most cases, the formed
micelles are concentrically clustered around the interface (see Figure 5a–e), due to capillary waves
formed on the surface of a drop under the influence of external fluid flow [20]. “Viscous fingering”
can be seen in Figure 5f, which occurs due to non-uniform penetration arising when a less viscous
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fluid is injected at high relative velocity into a more viscous one. At 293 K, the viscosities of THF and
water are 0.63 and 1 mPas, respectively, supporting this assumption. Viscous fingering did not occur in
Figure 5k,l, although the flow rate of the organic phase was exactly the same as in Figure 5f, probably
because Qa was higher than in Figure 5f, and the difference in velocity between the two streams was
not sufficiently high.
Due to the 3D geometry of the capillaries, the aqueous phase fully surrounds the organic phase
and de-wets it from the walls of the outer capillary. Since the micelles are formed at the liquid–liquid
interface, which is displaced from the walls, the deposition of the micelles onto the walls should be
less pronounced compared with 2D polydimethylsiloxane microfluidic devices. However, a limited
amount of deposited nanoparticles are visible in Figure 5a–d,k.
By increasing the water flow rate from 1 to 15 mL¨h´1 at a constant organic phase flow rate of
0.6 mL¨h´1, the interface is stretched from a hemisphere (Figure 5i) to an extended cylinder (Figure 5j),
because the shear force acting on the interface from the surrounding aqueous stream overcomes the
transient interfacial tension. It is interesting to note that the interface has entirely different shapes in
Figure 5f,i, although the flow rate ratio was very similar. However, when the flow rates of both fluids
are increased at constant flow rate ratio, it has more impact on the injection velocity of the organic
phase than on the aqueous phase velocity. As a result, in Figure 5f the velocity of the organic phase in
the orifice significantly surpasses the velocity of the aqueous phase and in Figure 5i both streams have
a similar velocity.
3.3. Parameters Affecting the Diameter of Polymeric Micelles
3.3.1. Copolymer Type
Table 2 shows the mean size of polymeric micelles from three different copolymers, two producing
techniques, and two organic solvents. Polydispersity index (PDI) is a measure of broadness of particle
size distribution. It can be seen that no significant difference in the micelle size was observed using
different copolymers.
Table 2. The Diameter and Polydispersity index (PDI) of micelles formed using different copolymers,
fabrication techniques and organic solvents. The copolymer concentration in the organic phase used
for preparation of drug-free micelles was 1 mg¨mL´1. The organic phase used for preparation of
drug-loaded micelles contained 0.6 mg¨mL´1 of fluconazole and 1.5 mg¨mL´1 of the copolymer.
In membrane experiments, the pore size was 20 µm, the organic phase flow rate was 9.62 mL¨min´1 (the
flux was 600 L m2h´1), the organic phase volume was 5 mL, and the aqueous phase volume was 25 mL.
Organic
Solvent Technique
Drug-Free Micelles Drug-Loaded Micelles
PEG-b-PCL
(A)
PEG-b-PCL
(B)
PEG-b-PCL
(C)
PEG-b-PCL
(A)
PEG-b-PCL
(B)
PEG-b-PCL
(C)
Acetone
Microfluidic
D (nm) 70 ˘ 9 55 ˘ 4 58 ˘ 8 87 ˘ 12 112 ˘ 11 84 ˘ 17
PDI 0.177 0.193 0.120 0.205 0.213 0.203
Membrane
D (nm) 53 ˘ 7 48 ˘ 7 53 ˘ 4 51 ˘ 7 63 ˘ 5 49 ˘ 0.49
PDI 0.212 0.225 0.200 0.215 0.195 0.149
THF
Microfluidic
D (nm) 61 ˘ 15 53 ˘ 9 54 ˘ 11
PDI 0.264 0.204 0.236
Membrane
D (nm) 46 ˘ 7 41 ˘ 8 48 ˘ 3
PDI 0.261 0.193 0.206
3.3.2. Organic Solvent
Even though organic solvent was evaporated under vacuum, the solvents may still remain
traceable in the final sample, so THF and acetone were chosen because of their low toxicity and good
fluconazole (only in acetone) and PEG-b-PCL solubility [21]. From Table 2 it can be concluded that
from both microfluidic and membrane preparation techniques and for all copolymers the size of
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micelles when using acetone as solvent was larger than using THF, even though the difference was
minor. Laouini et al. [21] obtained larger micelles when using THF but found the diameter of micelles
were largely unaffected by the solvent type. Such differences are most likely attributable to different
solubility of the polymer in water–THF and water–acetone mixtures and different viscosities of the
two solvents.
3.3.3. Micelles Preparation Techniques
As shown in Table 3 and Figure 6, drug-free micelles prepared in the Dispersion Cell were smaller
than the micelles prepared using microfluidic device. It can be explained by the fact that in the
Dispersion Cell, the organic phase was injected through a 20 µm pore-sized membrane, while in the
microfluidic device the dispersed phase was injected through an orifice with a diameter of 160 µm.
The same trend was observed when fluconazole was loaded into the hydrophobic core of the micelles,
with even more significant difference between the membrane and microfluidic device. For example,
the size of fluconazole-loaded micelles produced in the membrane device was 49–63 nm, depending of
the type of the copolymer used (Table 2). On the other hand, the size of fluconazole-loaded micelles
produced in the microfluidic device was 84–112 nm, which is a significant increase in the micelle size
by 71%–78%.
Experiments in the Dispersion Cell have also been done with direct injection of the organic
phase into the aqueous phase without using penetration through the membrane to reveal the effect of
membrane at the same stirrer speed of 700 rpm, injection rate of the organic phase of 9.62 mL¨min´1
and copolymer concentration in acetone of 1 mg¨mL´1. As shown in Table 3, for all three copolymers
investigated, the size of micelles produced without injection of the organic phase through the
membrane was significantly larger than the size of micelles produced by membrane permeation. It is
clear that the micelle size can be controlled to a certain extent by hydrodynamic conditions that can be
accurately controlled in the membrane device. Similar results were obtained for polymeric micelles [21]
and liposomes [22] using membranes with different pore sizes. In the absence of membrane, the organic
phase is injected through a single hole at the bottom of the stirred cell, which means that organic
solvent concentration in the aqueous phase is non-uniform on the micro-scale, with a very high
concentration near the injection hole and low concentration elsewhere. In the case of membrane
injection, the organic phase stream is split into numerous micro-jets, which come into contact with
an aqueous phase. Since the pores are regularly arranged over the whole membrane surface, it leads
to uniform mixing on the micro-scale without any bulk mixing.
Another important consequence of direct solvent injection is that the particle size distribution
was unpredictable and reproducibility of the experiment was extremely low, as illustrated in Figure 7.
This indicates that the use of a fixed pore size membrane provides essential consistency to the system
and allows control over particle sizes. Reproducibility of stirred cell with membrane and microfluidic
device is discussed in Section 3.6.
Table 3. The mean diameter of the drug-free micelles prepared using three copolymers dissolved in
acetone from three different preparation techniques. The organic phase was 1 mg¨mL´1 PEG-b-PCL
in acetone.
Preparation Technique
PEG-b-PCL (A) PEG-b-PCL (B) PEG-b-PCL (C)
Diameter (nm) PDI Diameter (nm) PDI Diameter (nm) PDI
Stirred tank without membrane 80 ˘ 6 0.205 83 ˘ 10 0.123 69 0.201
Microfluidic device 70 ˘ 9 0.177 55 ˘ 4 0.193 58 ˘ 8 0.120
Stirred tank with membrane 53 ˘ 8 0.212 48 ˘ 4 0.254 53 ˘ 5 0.200
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3.3.4. Aqueous/Organic Phase ratio
Figure 8 shows the particle size distribution for micelles generated from the same co-flow
microfluidic device under different aqueous/organic volume ratio. These illustrate that there are no
significant differences of particles diameters among different Qa/Qo values. Laouini et al. [21] found
that the diameter of micelles generated from membrane device uniformly decreased when increasing
the aqueous/organic phase ratio.
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Aqueous phase flow rates Qa were fixed to 5 mL¨h´1 for all four experiments. The organic phase was
composed of 1 mg¨mL´1 of PEG-b-PCL (B) dissolved in acetone.
3.4. Fluconazole-Loaded Micelles
Fluconazole is a triazole antifungal agent that is clinically widely used due to its advantages of
excellent bioavailability and low toxicity [23]. Fluconazole was added into organic phase solution to
prepare micelles with their hydrophobic cores loaded with the drug. Because of the low solubility
of fluconazole in THF, only acetone was used as the organic solvent for organic phase. The mean
diameters of fluconazole-loaded micelles are provided in Table 2. Figure 9 shows the effect of drug
loading on the particle size distribution of micelles generated using microfluidic and membrane
devices. It can be seen that under all process conditions, drug-loaded micelles were larger than
drug-free micelles, which agrees with the results of similar studies [24].
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Table 4. The mean diameter of micelles produced using membrane device as a function of drug 
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3.4.2. Effect of Fluconazole Concentration in Organic Phase on Encapsulation 
Figure 9. The particle size distribution of empty and drug-loaded micelles prepared using two different
devices: (a) Microfludic; and (b) Membrane. For drug-free micelles, the organic phas concentration was
1 mg¨mL´1 PEG-b-PCL (B) in acetone. For drug-loaded experiments, the organic phase was a mixture
of 0.6 mg¨mL´1 fluconazole and 1.5 mg¨mL´1 PEG-b-PCL (B) in acetone. The aqueous/organic phase
ratio was Qa/Qo = 0.71.
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3.4.1. Effect of Fluconazole Concentration in Organic Phase on Micelle Size
The impact of varied concentrations of fluconazole in the organic phase upon the size of the
micelles was investigated using only the membrane device. Table 4 shows the variation of the average
micelle size when the drug concentration in the organic phase increased from 0.5 to 2.5 mg¨mL´1 at the
fixed concentration of PEG-b-PCL (B) of 1 mg¨mL´1. It is clear that increasing the drug concentration
in the organic phase results in an increase in the micelle diameter. This can be attributed to the presence
of more drug that is loaded into the micelle, and demonstrates that the micelles are able to swell to
accommodate more drug—increasing the micelle size. Further investigation could establish whether
there is a maximum drug-loading capacity of PEG-b-PCL, where higher concentrations of drug are
merely precipitated into the bulk.
Table 4. The mean diameter of micelles produced using membrane device as a function of drug
concentration in the organic phase. The organic phase was 1 mg¨mL´1 PEG-b-PCL (B) in acetone with
designated drug content.
Drug Concentration in Organic Phase (mg¨mL´1) Diameter (nm) PDI
0.50 57 ˘ 0.4 0.220
1.00 62 ˘ 4 0.195
2.50 74 ˘ 0.5 0.172
3.4.2. Effect of Fluconazole Concentration in Organic Phase on Encapsulation
The amount of encapsulation of fluconazole from the organic phase was investigated from
micelles produced from the membrane device. HPLC analysis was performed using an Agilent 1100
HPLC System and a Supelco Ascentis C18 column, 5 µ, 150 mm ˆ 4.6 mm. The mobile phase was
methanol:water (97:3, v/v), and the analyte was detected at 292 nm. The flow rate of the mobile phase
was 1.2 mL¨min´1 and the column temperature was 30 ˝C. Quantification of fluconazole content was
based on a calibration curve created by assaying samples with concentrations of 0.1, 0.2, 0.25, 0.3
and 0.5 mg¨mL´1 of fluconazole. Drug-loaded micelles of 0.4 mg¨mL´1 per 1 mg¨mL´1 PEG-b-PCL
were centrifuged using an OptimaTM Ultracentrifuge (Beckman Coulter Inc, California, USA) at
50,000 rpm for 50 min at +4 ˝C to separate micelles from non-encapsulated drug. The supernatant
non-encapsulated drug was then assayed for fluconazole content using HPLC. Representative results
are shown in Figure 10—where fluconazole peak is visible beyond 3.5 min for each graph. A mass
balance was performed to determine the encapsulated drug.
Table 5 shows the drug encapsulation over time when using the membrane device with polymers
PEG-b-PCL (B) and PEG-b-PCL (C) to produce micelles. The results demonstrate the encapsulation of
drug, and the release of drug after a period of 48 h. On Day 0, fluconazole causes the micelles to swell
and is encapsulated within the micelles as displayed by results for both PEG-b-PCL (B) and PEG-b-PCL
(C). On Day 2, the concentration of fluconazole decreases significantly for both PEG-b-PCL (B) and
PEG-b-PCL (C), indicating a release of fluconazole into the bulk liquid.
Table 5. HPLC derived measurements of encapsulated drug immediately after producing
drug-loaded micelles (Day 0) and 48 h after producing micelles (Day 2) from the membrane
device. The fluconazole content in the organic phase was 0.4 mg¨mL´1 per 1 mg¨mL´1 PEG-b-PCL (B)
or PEG-b-PCL (C), respectively.
Polymer Encapsulated Drug (mg¨mL´1)
Day 0 Day 2
PEG-b-PCL (B) 0.23 0.17
PEG-b-PCL (C) 0.21 0.11
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3.5. Micelles Stability
The stability of polymeric micell s is one of the most challenging obstacles of applying them in
drug delivery systems since they re still a physically assemb d structure. Figure 11 il ustrates the
change of the average particle size of drug-loaded and empty micelles, which occurs during storage.
It shows hat while there is an initial rop in the micelle size, t tends to remain ste dy after just
over a week. The stability of polymeric micelles is affected by many factors such as polymer type,
concentration, and molecular weight [25]. Kim et al. [25] stated that the micelle stability depends
on the polymer concentration, which should be higher than the CMC to ensure th micelles are not
disintegrated into unimers. The stability of micelles can be directly linked to Ebend, which is the elastic
energy of the membrane interface of micelles [26]. Two models of calculating Ebend were proposed:
Helfrich model [27] and Hyde model [28] (the surfactant parameter model). In Hyde’s model, Ebend is
expressed depending on the surfactant parameter of the amphiphilic molecule (p), which depends on
the polar head area, the volume and the effective length of the hydrocarbon chain of the amphiphilic
chain, and the characteristic value of p in absence of bending stresses (p0). Here, no evidence has
shown that the micelles began to disintegrate to unimers during the testing period. It is likely that the
initial drop in size can be attributed to solvent that remains in the micelle after vacuum evaporation.
Indeed, small amounts of THF and acetone can remain in the sample and evaporate over time, causing
the micelles to shrink. In the case of empty micelles, the initial drop is less significant than with
drug-loaded micelles. This suggests that there might be a combined effect of evaporation of solvent
and release of fluconazole into the bulk liquid [29].
Membranes 2016, 6, 29 16 of 19
Membranes 2016, 6, 29 16 of 19 
 
3.5. Micelles Stability 
The stability of polymeric micelles is one of the most challenging obstacles of applying them in 
drug delivery systems since they are still a physically assembled structure. Figure 11 illustrates the 
change of the average particle size of drug-loaded and empty micelles, which occurs during storage. 
It shows that while there is an initial drop in the micelle size, it tends to remain steady after just over 
a week. The stability of polymeric micelles is affected by many factors such as polymer type, 
concentration, and molecular weight [25]. Kim et al. [25] stated that the micelle stability depends on 
the polymer concentration, which should be higher than the CMC to ensure the micelles are not 
disintegrated into unimers. The stability of micelles can be directly linked to Ebend, which is the elastic 
energy of the membrane interface of micelles [26]. Two models of calculating Ebend were proposed: 
Helfrich model [27] and Hyde model [28] (the surfactant parameter model). In Hyde’s model, Ebend is 
expressed depending on the surfactant parameter of the amphiphilic molecule (p), which depends 
on the polar head area, the volume and the effective length of the hydrocarbon chain of the 
amphiphilic chain, and the characteristic value of p in absence of bending stresses (p0). Here, no 
evidence has shown that the micelles began to disintegrate to unimers during the testing period. It is 
likely that the initial drop in size can be attributed to solvent that remains in the micelle after 
vacuum evaporation. Indeed, small amounts of THF and acetone can remain in the sample and 
evaporate over time, causing the micelles to shrink. In the case of empty micelles, the initial drop is 
less significant than with drug-loaded micelles. This suggests that there might be a combined effect 
of evaporation of solvent and release of fluconazole into the bulk liquid [29]. 
 
Figure 11 (a) The change in average particle size of micelles during storage: (a) Drug-free micelles 
produced in microfluidic device at Qa = 5 mL·h−1 and Qo = 0.71 mL·h−1. The organic phase was 1 
mg·mL−1 PEG-b-PCL (B) in THF; (b) Drug-loaded micelles produced using membrane device. The 
fluconazole content in the organic phase was 0.4 mg·mL−1 per 1 mg·mL−1 PEG-b-PCL (A); (c) 
Drug-loaded micelles produced using membrane device. The fluconazole content in the organic 
phase was 0.4 mg·mL−1 per 1 mg·mL−1 PEG-b-PCL (B). 
3.5.1. Zeta Potential 
Zeta potential is a measure of the electrical potential between the bulk fluid and the interface of 
a particle. A largely negative or positive value indicates high electrostatic forces leading to micelle 
stability [30]. 
The zeta potential was measured for fluconazole-loaded and empty micelles produced from 
membrane experiments (Table 6). The existence of a negative zeta potential can be associated to the 
carboxylic group contained on PLC chains [21]. Given that good stability of the micelles was 
observed (Figure 11), these low zeta potential values suggest a steric stability due to the PEG-b-PCL 
copolymers. After loading fluconazole, a lower absolute zeta potential was observed. This can be 
0
15
30
45
60
75
0 2 4 6 8 10 12 14 16 18 20 22 24 26 28 30
Pa
rt
ic
le
 S
iz
e 
(n
m
)
Days after production of sample (days)
(a)
(b)
(c)
Figure 11. (a) The change in average particle size of micelles during storage: (a) Drug-free micelles
produced in microfluidic device at Qa = 5 mL¨h´1 and Qo = 0.71 mL¨h´1. The organic phase was
1 mg¨mL´1 PEG-b-PCL (B) in THF; (b) Drug-loaded micelles produced using membrane device.
The fluconazole content in the organic phase was 0.4 mg¨mL´1 per 1 g¨mL´1 PEG-b-PCL (A);
(c) Drug-loaded micelles produced using membrane device. The fluconazole content in the organic
phase as 0.4 g¨mL´1 per 1 mg¨mL´1 PEG-b-PCL (B).
Zeta Potential
Zeta potential is a measure of the electrical potential between the bulk fluid and the interface of
a particle. A largely negative or positive value indicates high electrostatic forces leading to micelle
stability [30].
The zeta potential was measured for fluconazole-loaded and empty micelles produced from
membrane experiments (Table 6). The existence of a negative zeta potential can be associated to the
carboxylic group contained on PLC chains [21]. Given that good stability of the micelles was observed
(Figure 11), these low zeta potential values suggest a steric stability due to the PEG-b-PCL copolymers.
After loading fluconazole, a lower absolute zeta potential was observed. This can be attributed to
some of the drug adsorbing to the surface of the micelle and shielding the negative charge. Given the
relatively high stability of the micelles found in Figure 11, it can be concluded once again that the
micelles exhibit a strong steric stability despite the presence of a drug.
Table 6. The zeta potential of micelles formed by injecting 5 mL of the organic phase into 25 mL of
water through the membrane. The organic phase for drug-free micelles was 1 mg¨mL´1 of PEG-b-PCL
in acetone. The organic phase for drug-loaded micelles was 1 mg¨mL´1 of fluconazole per 1 mg¨mL´1
of PEG-b-PCL in acetone.
Micelle Type
Zeta Potential (mV)
PEG-b-PCL (A) PEG-b-PCL (B) PEG-b-PCL (C)
Drug free ´11 ´12 ´12
Drug loaded ´7 ´5 ´6
3.6. Process Reproducibility
Reproducibility of the particle size distribution of micelles was estimated by repeating one
membrane and one microfluidic experiment three times. For microfluidic experiment, the organic phase
was 1 mg¨mL´1 of the copolymer dissolved in acetone and Qa/Qo = 7. For membrane experiment,
5 mL of the organic phase composed of 1 mg¨mL´1 of the copolymer dissolved in acetone was injected
Membranes 2016, 6, 29 17 of 19
into 25 mL of water. It can be seen from Figure 12 that the both preparation techniques gave a very
good reproducibility in terms of the average micelle size produced under the same process conditions.
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Figure 12. Reproducibility of experiments: (a) co-flow glass capillary microfluidic device; and
(b) membrane device.
4. Conclusions
A novel co-flow glass capillary microfluidic device with 160 µm orifice size and a stirred cell
with 20 µm pore-sized membrane were used to produce polymeric micelles composed of hydrophobic
poly(caprolactone) (PCL) core and hydrophilic poly(ethylene) glycol (PEG) shell. Block copolymers
composed of PEG and PCL with three different PEG/ε-CL mole ratios and molecular weights
were successfully synthesized and used as building blocks for the preparation of both empty and
fluconazole-loaded micelles. The organic phase was copolymer dissolved in THF or acetone for
empty micelles preparation and a mixture of copolymer and fluconazole dissolved in acetone for
drug-loaded experiments. It was found that the micelles produced from the membrane device were
smaller than those produced from microfluidic device and the aqueous/organic volumetric ratio was
found to have no noticeable effect on the diameter of the micelles. After loading fluconazole in the
core, the diameter of micelles increased as expected for all copolymers tested and both preparation
techniques. The micelles produced were relatively stable with an initial drop in size, probably caused
by evaporation of residual solvent and/or release of fluconazole into the bulk liquid. The preparation
methods based on membrane and microfluidic micromixing were simple, effective and reproducible.
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